Arcadia Biosciences, Inc. (RKDA) › Shareholders' EquityArcadia Biosciences, Inc. (RKDA) — Shareholders' EquityAnnual figures by period end, from SEC filings.2017-12-31: $8.01M2018-12-31: $12.81M2019-12-31: $8.32M2020-12-31: $28.55M2021-12-31: $31.20M2022-12-31: $20.90M2023-12-31: $12.70M2024-12-31: $6.22M2025-12-31: $4.14M$4.14M2017-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$4.14M-33.5%2026-03-26Balance as of period end2024-12-31$6.22M-51.0%2026-03-26Balance as of period end2023-12-31$12.70M-39.2%2026-03-26Balance as of period end2022-12-31$20.90M-33.0%2025-03-25Balance as of period end2021-12-31$31.20M+9.3%2024-03-28Balance as of period end2020-12-31$28.55M+243.0%2023-03-30Balance as of period end2019-12-31$8.32M-35.0%2022-03-31Balance as of period end2018-12-31$12.81M+60.0%2021-03-31Balance as of period end2017-12-31$8.01M—2020-03-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)